Embecta (NASDAQ:EMBC) Downgraded to Buy Rating by Wall Street Zen

Embecta (NASDAQ:EMBC) was downgraded by investment analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a note issued to investors on Saturday.

A number of other research analysts also recently weighed in on EMBC. Weiss Ratings reiterated a “hold (c-)” rating on shares of Embecta in a report on Wednesday, January 21st. BTIG Research reissued a “buy” rating and issued a $25.00 target price on shares of Embecta in a research note on Friday. One research analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $18.50.

Embecta Stock Up 3.7%

NASDAQ EMBC opened at $10.86 on Friday. The firm has a market cap of $643.02 million, a P/E ratio of 4.58 and a beta of 1.11. Embecta has a 12-month low of $9.20 and a 12-month high of $18.07. The company’s 50 day moving average is $11.76 and its 200-day moving average is $12.96.

Embecta (NASDAQ:EMBC) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.04. The company had revenue of $261.20 million during the quarter, compared to analyst estimates of $258.07 million. Embecta had a negative return on equity of 26.66% and a net margin of 12.92%.The firm’s quarterly revenue was down .3% on a year-over-year basis. During the same quarter last year, the company earned $0.65 earnings per share. Embecta has set its FY 2026 guidance at 2.800-3.00 EPS. Equities analysts expect that Embecta will post 2.85 EPS for the current year.

Institutional Investors Weigh In On Embecta

Institutional investors have recently added to or reduced their stakes in the stock. Exchange Traded Concepts LLC grew its holdings in Embecta by 519.2% during the 3rd quarter. Exchange Traded Concepts LLC now owns 124,429 shares of the company’s stock worth $1,756,000 after acquiring an additional 104,334 shares in the last quarter. Teacher Retirement System of Texas raised its holdings in shares of Embecta by 365.7% in the 3rd quarter. Teacher Retirement System of Texas now owns 372,451 shares of the company’s stock valued at $5,255,000 after purchasing an additional 292,477 shares in the last quarter. Squarepoint Ops LLC lifted its position in shares of Embecta by 103.6% during the 2nd quarter. Squarepoint Ops LLC now owns 403,412 shares of the company’s stock worth $3,909,000 after purchasing an additional 205,311 shares during the last quarter. American Century Companies Inc. grew its stake in shares of Embecta by 36.3% during the second quarter. American Century Companies Inc. now owns 5,195,948 shares of the company’s stock worth $50,349,000 after purchasing an additional 1,382,537 shares in the last quarter. Finally, Allianz Asset Management GmbH increased its holdings in Embecta by 68.4% in the second quarter. Allianz Asset Management GmbH now owns 52,044 shares of the company’s stock valued at $504,000 after buying an additional 21,144 shares during the last quarter. Institutional investors own 93.83% of the company’s stock.

Embecta News Roundup

Here are the key news stories impacting Embecta this week:

• Positive Sentiment: Q1 results beat expectations — EPS $0.71 vs. $0.67 consensus and revenue $261.2M vs. $258.1M; management provided slide deck and press release that highlight execution on core products. Embecta Q1 Results
• Positive Sentiment: BTIG reaffirmed a Buy and set a $25 price target (material upside vs. current levels), which can boost investor sentiment and momentum. BTIG Reaffirmation
• Positive Sentiment: Board declared a quarterly cash dividend of $0.15/share (annualized yield ~5.7%) — supports income-focused investors and may attract yield-seeking flows. Dividend Announcement
• Neutral Sentiment: Earnings call materials and transcripts are available (slides, call transcript, presentation) for investors wanting detail on product trends, margin drivers and regional performance; these provide transparency but no new catalyst by themselves. Earnings Presentation
• Negative Sentiment: FY2026 EPS guidance of $2.80–3.00 is modestly below sell‑side consensus (~$2.89), which could cap upside as investors weigh near-term growth headwinds vs. one-time execution positives. Guidance Details

Embecta Company Profile

Embecta Corp (NASDAQ: EMBC) is a pure-play diabetes care company that was spun off from Becton, Dickinson and Company on July 1, 2021. Headquartered in Franklin Lakes, New Jersey, Embecta focuses exclusively on the development, manufacturing and commercialization of products that enable insulin delivery and blood glucose monitoring for people with diabetes.

The company’s product portfolio includes insulin infusion sets, durable and patch pumps, pen needles, infusion tubing, blood glucose test strips, lancets and lancing devices.